Long-term safety and effectiveness of etanercept in JIA: an -- &#; Methods: JIA patients newly exposed to etanercept were documented in the BiKeR registry from January to March , and baseline characteristics, effectiveness, and : Giulia Armaroli, Ariane Klein, Ariane Klein, Gerd Ganser, Michael J. Ruehlmann, Frank Dressler, Anto

Safety and Effectiveness of Long-term Intravenous-- &#; Objective: To evaluate the long-term safety and effectiveness of intravenous edaravone therapy for patients with ALS in a real-world clinical setting. Design, setting, and

Long-Term Safety and Effectiveness of Lubiprostone, a -- &#; The short-term (-week) effectiveness and safety of lubiprostone had been previously established in two placebo-controlled trials in patients with chronic constipation [, ]. : Anthony J. Lembo, John F. Johanson, Henry P. Parkman, Satish S. Rao, Philip B. Miner, Ryuji Ueno

Long-term safety and effectiveness of sildenafil citrate in Because the major focus of this study was safety, and it was designed before the development and validation of patient-reported outcomes to assess satisfaction with the quality of erection : James G McMurray, Robert A Feldman, Stephen M Auerbach, Herb DeRiesthal, Neal Wilson

Long-term safety and effectiveness of mycophenolate Introduction

Long‐term safety and effectiveness of berotralstat for -- &#; The ongoing, open-label, phase , APeX-S study is a large, geographically diverse, long-term study to assess the safety and effectiveness of berotralstat in patients with HAE-C

Long-Term Safety and Effectiveness of Adalimumab in -- &#; The long-term ( weeks) safety and efficacy of adalimumab were confirmed in VISUAL III, an open-label extension study of VISUAL I and II . Although the long-term use of

Long-term Safety, Tolerability and Effectiveness Study of -- &#; Confirmed disability improvement is a decrease from baseline in Expanded Disability Status Scale (EDSS) score sustained for at least , or months EDSS consists of seven

Long-Term Follow-Up Safety and Effectiveness of CT -- &#; The efficacy was judged according to the weighted values that are specifically divided into ineffective, remission, and cure: NRS-WV < % was ineffective, % ≤ NRS-WV ≤ %

Safety and Effectiveness of Long-term Intravenous Objective To evaluate the long-term safety and effectiveness of intravenous edaravone therapy for patients with ALS in a real-world clinical setting. Design, Setting, and Participants

Long-term safety and effectiveness of etanercept in JIA: an -- &#; Long-term safety and effectiveness of etanercept in JIA: an -year experience from the BiKeR registry Giulia Armaroli, Ariane Klein, Gerd Ganser, Michael J. Ruehlmann, Frank Dressler, Anton Hospach, Kirsten Minden, Ralf Trauzeddel, Ivan Foeldvari, Jasmin Kuemmerle-Deschner, Frank Weller-Heinemann, Andreas Urban & Gerd Horneff

Long-Term Safety and Effectiveness of Iron-Chelation -- &#; Original Article from The New England Journal of Medicine — Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major logo- logo-

Long-term safety and effectiveness of natalizumab natalizumab is a highly efficacious therapy for the treatment of relapsing-remitting multiple sclerosis (rrms), as demonstrated in clinical trials and a number of real-world studies. – data collected during long-term real-world treatment complement and extend results from randomised clinical trials; real-world data also provide clinicians and

Long-Term Safety and Effectiveness of Thyrotropin Alfa in -- &#; Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study Rie Kanamori, Shiho Yamane & Takeshi Seto Advances in Therapy , – ( ) Cite this article Accesses

Long-term safety and effectiveness of denosumab in -- &#; No new safety signals were identified. The long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis in daily clinical practice was confirmed and no new safety signals were identified. Introduction Denosumab is a humanized IgG monoclonal antibody that was approved for the treatment of osteoporosis in Japan in .

Long-Term Safety and Effectiveness of the “OptEase” Vena -- &#; To assess the long-term safety and effectiveness of the OptEase inferior vena cava (IVC) filter. Materials and Methods In this Institutional Review Board-approved, retrospective study, we reviewed data of patients who received

Long-term Safety, Tolerability and Effectiveness Study of -- &#; Confirmed disability improvement is a decrease from baseline in Expanded Disability Status Scale (EDSS) score sustained for at least , or months EDSS consists of seven functional systems and an ambulation score that are then combined to determine the EDSS steps (ranging from (normal) to (death due to MS)).

Long-Term Safety and Effectiveness of Linagliptin in -- &#; The aim of this study was to investigate the long-term safety and effectiveness of linagliptin in routine clinical practice. Methods This was a prospective, observational, post-marketing surveillance study conducted over weeks in patients with type diabetes mellitus who started linagliptin monotherapy.

Bronchial thermoplasty: Long-term safety and -- &#; The proportion of subjects experiencing severe exacerbations and emergency department (ED) visits and the rates of events in each of years to remained low and were less than those observed in the months before BT treatment (average -year reduction in proportions: % for exacerbations and % for ED visits).

Safety and Effectiveness of Long-term Intravenous Left panels show treatment slope in amyotrophic lateral sclerosis (ALS) Functional Rating Scale–Revised (ALSFRS-R) score points per month during follow-up for all patients, EFAS subgroup, and non-EFAS subgroup. Box and whisker plots show median (central line), IQR (boxes), and . &#; IQR (whiskers), with individual points representing outliers.

Long-term Safety and Effectiveness of Growth Hormone -- &#; Go to Brief Summary: The purpose of this study is to evaluate the long-term safety and effectiveness of growth hormone (Eutropin Inj./Eutropin plus Inj.) treatment with GHD (Growth Hormone Deficiency), TS (Turner Syndrome),CRF (Chronic Renal Failure), SGA (Small for Gestational Age), and ISS (Idiopathic Short Stature). Study Design Go to

Long-term safety and effectiveness of mycophenolate -- &#; Mycophenolate mofetil (MMF) is an immunosuppressive drug that has proved its effectiveness and safety for the induction and maintenance therapy of LN in a number of clinical trials [ – ], and its therapeutic value has been highlighted in different systematic reviews [ , ].

Long-term safety and effectiveness of abatacept in -- &#; However, long-term safety and effectiveness data are lacking. Therefore, the present report describes a long-term analysis (-year follow-up) of overall safety, focusing on serious infections and malignancies as priority events, as well as effectiveness, using real-world postmarketing surveillance data. Materials and methods

[PDF] Long-term safety and effectiveness of lurasidone in -- &#; Open-label treatment with flexibly dosed lurasidone (- mg/d) was generally safe, well tolerated, and effective over a -month period in patients who had completed a preceding -week, double-blind study. Long-term safety and tolerability of lurasidone in schizophrenia: a -month, double-blind, active-controlled study

Long-Term Safety and Effectiveness of the “OptEase” Vena -- &#; To assess the long-term safety and effectiveness of the OptEase inferior vena cava (IVC) filter. Materials and Methods In this Institutional Review Board-approved, retrospective study, we reviewed data of patients who received an OptEase filter at our institution from to .

Long‐term safety and effectiveness of levodopa‐carbidopa -- &#; The aim of this study is to assess the long‐term safety and effectiveness of LCIG infusion in advanced Parkinson's disease (PD) patients with motor fluctuations and its effect in nonmotor symptoms. Methods Adverse events (AE) and their management, clinical motor, and nonmotor aspects were assessed up to years.

THU LONG-TERM SAFETY AND Objectives: To report safety and efficacy of UPA vs ADA up to weeks in patients with RA from the ongoing long-term extension (LTE) of SELECT-COMPARE. Methods: Patients were randomized to once daily (QD) UPA

Long‐term safety and effectiveness of brexpiprazole in -- &#; In patients aged years or older, brexpiprazole was also safe and maintained long-term therapeutic effects. Therefore, brexpiprazole may provide a useful treatment option for older patients with schizophrenia; however, these results need to be interpreted with caution, as the number of patients aged over years was low in this study.

Bronchial thermoplasty: Long-term safety and -- &#; The proportion of subjects experiencing severe exacerbations and emergency department (ED) visits and the rates of events in each of years to remained low and were less than those observed in the months before BT treatment (average -year reduction in proportions: % for exacerbations and % for ED visits).

Safety and Effectiveness of Long-term Intravenous Left panels show treatment slope in amyotrophic lateral sclerosis (ALS) Functional Rating Scale–Revised (ALSFRS-R) score points per month during follow-up for all patients, EFAS subgroup, and non-EFAS subgroup. Box and whisker plots show median (central line), IQR (boxes), and . &#; IQR (whiskers), with individual points representing outliers.